Literature DB >> 6162830

A controlled evaluation of combined radiation and bleomycin therapy for squamous cell carcinoma of the esophagus.

J D Earle, R D Gelber, C G Moertel, R G Hahn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6162830     DOI： 10.1016/0360-3016(80)90318-1

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  5 in total

1.  [The present status of radiotherapy and combined modality in the treatment of esophageal carcinoma (author's transl)].

Authors:  E Scherer; K B Sachse
Journal:  Langenbecks Arch Chir       Date:  1981

2.  Long-term outcome of mitomycin C- and 5-FU-based primary radiochemotherapy for esophageal cancer.

Authors:  Maria Wolf; Franz Zehentmayr; Maximilian Niyazi; Ute Ganswindt; Wolfgang Haimerl; Michael Schmidt; Dieter Hölzel; Claus Belka
Journal:  Strahlenther Onkol       Date:  2010-06-24       Impact factor: 3.621

Review 3.  Combined modality therapy for esophageal cancer.

Authors:  Z Gamliel; M J Krasna
Journal:  Curr Oncol Rep       Date:  1999       Impact factor: 5.075

Review 4.  [Radiotherapy in the multimodal treatment of esophageal carcinoma. A review].

Authors:  P Fritz; M Wannenmacher
Journal:  Strahlenther Onkol       Date:  1997-06       Impact factor: 4.033

5.  A retrospective study on radiotherapy and radiochemotherapy in esophageal cancer.

Authors:  C M Kim; W S Hong; J O Lee; T W Kang; Y H Kim; C G Cho; K H Koh; S Y Yoo
Journal:  Korean J Intern Med       Date:  1988-01       Impact factor: 2.884
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.